Skip to content

Effect of SN-2 palmitate on intestinal discomfort and bone health in middle-aged and elderly people and its mechanism

Effect of SN-2 palmitate on intestinal discomfort and bone health in middle-aged and elderly people and its mechanism

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026480
Enrollment
Unknown
Registered
2019-10-12
Start date
2020-01-01
Completion date
Unknown
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

constipation

Interventions

Experimental group:take one bag of 30g high OPO (65%) protein powder every day for 6 months
Control group:take one bag of 30g low OPO (14%) protein powder every day for 6 months

Sponsors

Peking University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 45-75 years; 2. Ultrasound bone strength T value <-1 (50% volunteers); 3. Self-reported difficulty in defecation.

Exclusion criteria

Exclusion criteria: 1. Those with severe metabolic disease or chronic intestinal inflammation; 2. Those who took VD, calcium supplements, probiotic products and laxatives in the past two weeks; 3. Those who took SN-2 palmitate related products in the past month; 4. Those who have had intestinal and anal surgery, and who have been treated with constipation drugs but did not work; 5. Anxiety or mental disorder; 6. Those who may be allergic to the experimental intervention protein powder.

Design outcomes

Primary

MeasureTime frame
Scores of intestinal discomfort;

Secondary

MeasureTime frame
Ultrasound bone strength;Bone density;

Countries

China

Contacts

Public ContactZhang Yumei

Peking University Health Science Center

zhangyumei@bjmu.edu.cn+86 10 82801575

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026